bpc 157 human dosage recommendations bpc-157 typical use Body Protecting Compound (BPC-157 ): Overview, Potential Benefits, and Safety Tell me more about dosage
Description
Among 1252 patients with non-squamous NSCLC histology, 68% had a diagnosis of adenocarcinoma, 12% had large cell histology and 20% had other histologic subtypes
The published medical literature includes discussion of BPC-157 as having been explored for GI indications (including a compound referred to as PL 14736 in phase II context), but the human clinical evidence base for the musculoskeletal claims people make online is not robust
The difference in results between local and non-local administration remains unclear from available research
What it is
Let our experts create a plan that brings out the best in you
